$3.49 -0.18 (-4.90%)
2/10/2012 3:59 PM

Antigenics, Inc. (NASDAQ:AGEN)

CAPS Rating: 2 out of 5

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

Recs

0
Player Avatar Vavoom11 (99.88) Submitted: 6/3/2009 11:13:13 AM : Underperform Start Price: $16.62 AGEN Score: +25.60

Short the pop!

Report this Post Add Comment

Featured Broker Partners


Advertisement